Maryland

Maryland has cemented its status as a premier global life sciences hub, consistently ranked as a top-three biopharmaceutical cluster in the US.

The state's ecosystem is uniquely defined by its unparalleled proximity to critical federal regulatory bodies and research institutions, including the National Institutes of Health (NIH) and the US Food and Drug Administration (FDA).

This strategic "BioHealth Capital Region" location facilitates a seamless bench-to-bedside pipeline, supported by world-class academic research powerhouses like Johns Hopkins University and the University of Maryland.

Maryland is a leader in biotechnology innovation, particularly in high-growth subsectors such as cell and gene therapy, personalized medicine and vaccine development.

The state's robust biomanufacturing infrastructure has attracted global industry giants like AstraZeneca, Kite Pharma and GSK, alongside a thriving community of over 2,700 life sciences companies.

In the realm of medical device and healthcare innovation, Maryland leverages its expertise in artificial intelligence (AI) and robotics to pioneer next-generation diagnostic tools and digital health solutions.

Extensive state-backed incentives, including the Biotechnology Investment Incentive Tax Credit (BIITC), continue to drive significant venture capital and private equity into the region.

With a highly educated STEM workforce and a collaborative culture between academia, industry and government, Maryland remains at the forefront of solving the world's most complex medical challenges.